Show simple item record

FieldValueLanguage
dc.contributor.authorSmith, Ebonyen
dc.contributor.authorTran, Tuanen
dc.contributor.authorGillies, Alexen
dc.contributor.authorYeung, Shannaen
dc.contributor.authorMa, Patrick Een
dc.date.accessioned2022-04-28T02:44:47Z
dc.date.available2022-04-28T02:44:47Z
dc.date.issued2022
dc.identifier.urihttps://hdl.handle.net/2123/28247
dc.description.abstractPURPOSE: To describe two cases of multiple evanescent white dot syndrome (MEWDS) occurring after administration of COVID-19 vaccine. STUDY DESIGN: Case Report. RESULTS: Two patients presented soon after receiving their second-dose of the BNT162b2 Pfizer-BioNTech COVID-19 vaccine with findings consistent with MEWDS. Due to the significant reduction in vision, patients were treated with a short dose of oral corticosteroids. Both had complete resolution of their symptoms, visual acuity and retinal findings. CONCLUSIONS: The onset of inflammatory ocular adverse events following COVID-19 vaccinations suggest a maladaptive inflammatory response triggered by the vaccine. Onset of symptoms after COVID-19 vaccinations should prompt the ophthalmologist to assess for these rare adverse events. Despite the extremely rare occurrences of ocular adverse events, we unequivocally recommend that patients receive the full vaccine due to the vast benefit for both individuals and society that far outweighs the inconsiderable risk of harm.en
dc.language.isoenen
dc.rightsOther
dc.subjectCOVID-19en
dc.subjectCoronavirusen
dc.titleMultiple Evanescent White Dot Syndrome following COVID-19 mRNA Vaccination in Two Patients.en
dc.typeArticleen
dc.identifier.doi10.1080/09273948.2022.2032198
usyd.facultySeS faculties schools::Faculty of Medicine and Healthen


Show simple item record

Associated file/s

There are no files associated with this item.

Associated collections

Show simple item record

There are no previous versions of the item available.